Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Autoimmune Drugs Market Research Reports

Titlepublishedprice

Myasthenia Gravis - Pipeline Review, H2 2014

By Global Markets Direct
"...... therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development f......"
10-Dec-2014$2000

OpportunityAnalyzer: Celiac Disease - Opportunity Analysis and Forecast to 2023

By GlobalData
"...... on and there are no preventative medications. The anticipated launch of Alba/Teva’s larazotide acetate in 2018 in the US and 2019 in 5EU, followed by the launch of Alvine/AbbVie’s latiglutenase in 2019 and 2020 in the US and 5EU respectively are set ......"
30-Nov-2014$7995

Opportunity Analyzer: Celiac Disease - Opportunity Analysis and Forecast to 2018

By GlobalData
"...... n and there are no preventative medications. The anticipated launch of Alba/Teva’s larazotide acetate in 2018 in the US and 2019 in 5EU, followed by the launch of Alvine/AbbVie’s latiglutenase in 2019 and 2020 in the US and 5EU respectively are set t......"
19-Nov-2014$7995

Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2014

By Global Markets Direct
"...... comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players ......"
18-Nov-2014$2000

EpiCast Report: Celiac Disease – Epidemiology Forecast to 2023

By GlobalData
"...... thus interferes with nutrient absorption. Celiac disease can be difficult to diagnose because the symptoms vary between individuals and are non-specific, such as abdominal bloating and pain, diarrhea, constipation, and weight loss. Short-term malicio......"
10-Nov-2014$3995

Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2014

By Global Markets Direct
"...... with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key play......"
31-Oct-2014$2000

Celiac Disease - Pipeline Review, H2 2014

By Global Markets Direct
"...... ics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Celiac......"
31-Oct-2014$2000

Systemic Lupus Erythematosus - Pipeline Review, H2 2014

By Global Markets Direct
"...... tive analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved......"
31-Jul-2014$2000

Primary Biliary Cirrhosis - Pipeline Review, H1 2014

By Global Markets Direct
"...... ysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the t......"
15-Jun-2014$2000

Microscopic Polyangiitis (MPA) - Pipeline Review, H1 2014

By Global Markets Direct
"...... omparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players in......"
15-May-2014$2000

Avail upto 25% Discount on below Publisher Reports.